8.675  -0.435 (-4.77%)		06-16 16:00
Open: 9.5199 High: 9.5199 Volume: 134,213		Pre. Close: 9.11 Low: 8.48 Market Cap: 72(M)

Short term
Mid term
Targets	6-month :	12.25	1-year :	14.31
Resists	First :	10.49	Second :	12.25
Pivot price	9.59
Supports	First :	7.53	Second :	5.69
MAs	MA(5) :	9.62	MA(20) :	8.87
	MA(100) :	6.96	MA(250) :	6.06
MACD	MACD :	0.6	Signal :	0.7
%K %D	K(14,3) :	56.6	D(3) :	78.5
RSI	RSI(14): 50.8
52-week	High :	10.49	Low :	4.15

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ ECOR ] has closed above bottom band by 4.5%. Bollinger Bands are 21.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	9.53 - 9.58	9.58 - 9.62
Low:	8.36 - 8.42	8.42 - 8.47
Close:	8.58 - 8.68	8.68 - 8.75

electroCore, Inc. is a commercial-phase medical device enterprise whose focus lies in developing and bringing to market a variety of non-invasive vagus nerve stimulation (nVNS) therapies. Currently, the firm is advancing gammaCore, a prescription-only nVNS therapy specifically engineered for adults to acutely treat the discomfort associated with both migraine and episodic cluster headaches. Its flagship offering, the gammaCore Sapphire, is a portable, rechargeable, and refillable device intended for either regular or intermittent use over many years. Established in 2005, its corporate headquarters are situated in Rockaway, New Jersey.

Tue, 16 Jun 2026
Analysts’ Top Healthcare Picks: Intellia Therapeutics (NTLA), Electrocore (ECOR) - The Globe and Mail

Fri, 12 Jun 2026
electroCore (ECOR) ex-officer sells 80,000 shares, keeps 211,471 - Stock Titan

Tue, 02 Jun 2026
electroCore to Present at the Planet MicroCap Las Vegas 2026 Powered by MicroCapClub - Sahm

Fri, 29 May 2026
electroCore (ECOR) CFO sells 6,667 shares in open-market trade - Stock Titan

Tue, 26 May 2026
electroCore (ECOR) director boosts stake with 9,992-share open-market buy - Stock Titan

Wed, 06 May 2026
electroCore Announces First Quarter 2026 Financial Results - GlobeNewswire

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Devices
Shares Out	8 (M)
Shares Float	5 (M)
Held by Insiders	37.1 (%)
Held by Institutions	9.1 (%)
Shares Short	280 (K)
Shares Short P.Month	335 (K)

EPS	-1.77
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	-0.7
Profit Margin	-44.1 %
Operating Margin	-55.5 %
Return on Assets (ttm)	-58.1 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	42.5 %
Gross Profit (p.s.)	3.66
Sales Per Share	4.2
EBITDA (p.s.)	-1.73
Qtrly Earnings Growth	0 %
Operating Cash Flow	-7 (M)
Levered Free Cash Flow	-1 (M)

PE Ratio	-4.91
PEG Ratio	0
Price to Book value	-12.4
Price to Sales	2.06
Price to Cash Flow	-10.53

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.